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In the present study, we analysed the expression and locali-
zation of p21
Waf1/Cip1 in normal and malignant haematopoietic
cells. We demonstrate that in normal monocytic cells, protein
kinase C (PKC)-induced p21 gene activation, which is nuclear
factor-jB (NF-jB) independent, results in predominantly cyto-
plasmic localized p21 protein. In acute monocytic leukaemia
(M4, M5), monocytic blasts (N¼12) show constitutive cytoplas-
mic p21 expression in 75% of the cases, while in myeloid
leukaemic blasts (N¼10), low nuclear and cytoplasmic locali-
zation of p21 could be detected, which is also PKC dependent.
Constitutive p21 expression in monocytic leukaemia might
have important antiapoptotic functions. This is supported by
the ﬁnding that in U937 cells overexpressing p21, VP16-induced
apoptosis is signiﬁcantly reduced (20.070.9 vs 55.873.8%,
Po0.01, N¼5), reﬂected by a reduced phosphorylation of p38
and JNK. Similarly, AML blasts with high cytoplasmic p21 were
less sensitive to VP16-induced apoptosis as compared to AML
cases with low or undetectable p21 expression (42.25 vs 12.3%,
Po0.01). Moreover, complex formation between p21 and ASK1
could be demonstrated in AML cells, by means of coimmuno-
precipitation. In summary, these results indicate that p21 has
an antiapoptotic role in monocytic leukaemia, and that p21
expression is regulated in a PKC-dependent and NF-jB-
independent manner.
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Introduction
Acute myeloid leukaemia (AML) is characterized by an
accumulation of immature cells in the bone marrow, resulting
in the disruption of normal haematopoiesis.
1–3 The growth
advantage of the leukaemic population is in part linked to the
constitutive activation of intracellular proteins that trigger the
function of antiapoptotic proteins.
4,5 Recent studies have
indicated that nuclear factor-kB (NF-kB) is constitutively
expressed in AML cells, which is due to the activation of the
Ras/PI3 kinase pathway.
4,6–8 A recent study in normal mono-
cytes has suggested that the antiapoptotic function of NF-kBi si n
part mediated by the cytoplasmic p21
Waf1/Cip1 (p21) protein.
9,10
So far, p21, a member of the family of cyclin-dependent kinase
(CDK) inhibitors, was deﬁned as a nuclear protein. These
proteins function by inhibiting CDK1, -2, -4 and -6, and induce
cell cycle arrest at the G1/S boundary. This process allows the
cells to exit the cell cycle and differentiate.
11–16 Localization of
p21 in the cytoplasm has been connected to monocytic
differentiation, and is implicated in antiapoptotic func-
tions.
9,10,17 Cytoplasmic p21 can form a complex with apoptosis
signal-regulating kinase 1 (ASK1), preventing the activation of
the mitogen-activated protein (MAP) kinase cascade.
10 In
addition, p21 can bind to procaspase 3, preventing the
induction of apoptosis in HepG2 cells.
18,19 Finally, p21 has
been shown to be a downstream target of protein kinase B (PKB
(AKT)). Two sites in the carboxyl terminus of p21 are
phosphorylated by PKB, which enhances the stability of the
p21 protein and modulates binding of p21 to target proteins.
20,21
In view of the link between p21 and apoptosis, we questioned
whether p21 expression and localization is perturbed in
malignant haematopoietic cells and whether cytoplasmic
localization of p21 protects against the cytotoxic effects of
chemotherapy. The results demonstrate that p21 is not expressed
in unstimulated haematopoietic cells of monocytic and myeloid
origin. In addition, it is demonstrated that PMA is capable of
inducing p21 expression in a protein kinase C (PKC)-dependent
manner. In monocytic leukaemia, p21 is constitutively ex-
pressed and cytoplasmic localized, in contrast to myeloid
leukaemia where no cytoplasmic p21 was detected. We
postulate that cytoplasmic p21 protects these cells against the
effects of cytotoxic agents, as is reﬂected by a decrease in VP16-
induced apoptosis in p21-overexpressing cells and AML blasts
with constitutive p21 expression.
Materials and methods
Patient population and isolation of AML cells
Peripheral blood cells or bone marrow cells from 22 adult
untreated patients with AML were studied after informed
consent. The AML cases were deﬁned according to the
classiﬁcation of the French–American–British (FAB) committee
as M0–M6.
22 AML blasts were isolated by density-gradient
centrifugation. The cells were cryopreserved in aliquots of
20–30 10
6 cells in RPMI 1640 (Biowhittaker, Verviers,
Belgium) supplemented with 10% dimethylsulphoxide (DMSO;
Sigma, St Louis, MO, USA) and 10% foetal bovine serum (FBS;
Bodinco, Alkmaar, The Netherlands), employing a method of
controlled freezing and storage in liquid nitrogen. After thawing,
T-lymphocytes were depleted by 2-aminoethylisothioronium
bromide (AET)-treated sheep red blood cell (SRBC) rosetting.
The cell population consisted of more than 98% AML blasts, as
determined by May–Gru ¨nwald–Giemsa staining. Fluorescence-
activated cell sorting (FACS) analysis demonstrated o1% CD3
(Becton Dickinson, Sunnyvale, California, USA)-positive cells.
Preparation of monocytes and granulocytes
Peripheral blood cells were obtained from healthy volunteer
blood donors, and mononuclear cell suspensions were prepared
by Ficoll–Hypaque density-gradient centrifugation. T-lympho-
cytes were depleted by AET-treated SRBC rosetting. Monocytes
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and demonstrated a purity 495%, detected by FACS analysis
with anti-CD14 antibody (Becton Dickinson, Sunnyvale, CA,
USA).
Peripheral blood from healthy volunteers, anticoagulated with
0.32% sodium citrate, was used to isolate granulocytes, as
described by Koenderman et al.
23 In short, mononuclear cells
were removed by centrifugation over Fycoll-Paque (Amersham,
Upsala, Sweden), and erythrocytes were lysed with ice-cold
NH4Cl solution. Granulocytes were allowed to recover for
30min at 371C in RPMI 1640 (Bio Whittaker, Verviers, Belgium)
supplemented with 0.5% human serum albumin (HSA; CLB,
Amsterdam, The Netherlands). Before stimulation, cells were
resuspended in incubation buffer (20mM HEPES, 132mM NaCl,
6m M KCl, 1mM MgSO4, 1.2mM KH2PO4,5m M glucose, 1mM
CaCl2, 0.5% HSA). In all cases, the cell population isolated
consisted of 495% granulocytes, as determined by May–
Gru ¨nwald–Giemsa staining.
Cell culture
AML blasts were cultured at 371C, 5% CO2, at a density of
1 10
6/ml in RPMI 1640 media supplemented with 100U/ml
penicillin, 100mg/ml streptomycin (ICN, Costa Mesa, CA, USA)
and 10% FBS. Monocytes were cultured at 371C, 5% CO2,a ta
density of 1 10
6/ml in RPMI 1640 and 10% FBS. The human
growth factor-dependent cell lines AS-E2
24 and GF-D8
25 were
cultured in RPMI 1640 supplemented with 5% FBS and 10ng/ml
IL-3 (Genetics Institute Cambridge, MA, USA). The human cell
lines U937 (ATCC, Product No. CRL-1593.2), THP-1 (ATCC,
Product No. TIB-202) and HL-60 (ATCC, Product No. CCL-240)
were cultured in RPMI 1640 supplemented with 10% FBS. The
primitive human cell line KG1a (ATCC, Product No. CCL-2461)
was cultured in IMDM (ICN) with 20% FBS. In addition, U937
cells stable transfected with a ZnCl2 (180mM, 3 days)-inducible
p21 construct were used in conjunction with a mock-transfected
cell line for studying the cellular function of p21.
10,17
Reagents and antibodies
Antibodies against phosphorylated extracellular-signal-regu-
lated kinase (ERK), PKB, p38 and c-jun N-terminal kinase
(JNK) were obtained from New England Biolabs (Beverly, MA,
USA). Antibodies against p38, JNK, ASK1 and an antibody–
agarose conjugate for immunoprecipitation of p21 (C-19) were
obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
p21 antibody was purchased from Transduction Laboratories
(Lexington, KY, USA), and an antibody against actin was
obtained from Boehringer Mannheim (Mannheim, Germany).
Supershift antibodies for p50 and p65 were purchased from
Santa Cruz Biotechnology, as well as the Rb antibody. Horse-
radish peroxidase (HRP)-labelled secondary antibodies were
obtained from DAKO (Glostrup, Denmark).
Recombinant human (Rh) interleukin (IL)-1b was obtained
from Mekesson HBOC Bioservices (Rockville, MD, USA). Rh IL-
3 and granulocyte–monocyte-colony-stimulating factor (GM-
CSF) were purchased from Genetics Institute (Cambridge, MA,
USA), and phorbol 12-myristate 13-acetate (PMA) was obtained
from Sigma (St Louis, MO, USA) as well as actinomycin D. The
p38 MAPK inhibitor SB203580 and the NF-kB inhibitor SN-50
were obtained from Biomol (Plymouth Meeting, PA, USA). The
PI3K inhibitor Ly294002 was obtained from Alexis (San Diego,
CA, USA). MAP kinase/ERK kinase (MEK) 1 inhibitor U0126 was
obtained from Promega Corp. (Leiden, The Netherlands). The
PKC inhibitors bisindolylmaleimide I (BIM or GF 109203X),
chelerythrin and calphostin-C were obtained from Calbiochem
(Darmstadt, Germany). VP16 was purchased from TEVA
Pharming (Mijdrecht, The Netherlands). Radionucleotides and
the random hexamer primers p(CAN)6 were obtained from
Amersham (Buckinghamshire, UK). H2O2 was obtained from
Merck (Darmstadt, Germany). M-MLV-RT polymerase and
RNAse inhibitor were obtained from MBI Fermentas (St Leon-
Rot, Germany). Tri Reagent was purchased from MRC Molecular
Research Center Inc. (Cincinnati, OH, USA). The Quantitect
SYBR Green PCR Kit was obtained from Qiagen GmbH (Hilden,
Germany). The dNTPs were purchased from Invitrogen BV
(Breda, The Netherlands).
Combined annexin V/propidium iodide staining
procedure
Viability was assessed using an annexin V staining kit (IQ
Products, Groningen, The Netherlands), according to the
manufacturer’s recommendations. Brieﬂy, after 24h of culture
in RPMI 1640 medium supplemented with 10% FBS with or
without addition of VP16 (20mg/ml), cells were harvested,
resuspended in 100ml calcium buffer containing 5ml of annexin
V and incubated for 20min at 41C in the dark. Cells were
washed with 5ml calcium buffer, and subsequently incubated in
300ml calcium buffer containing 2.5ml of propidium iodide (PI)
for 10min in the dark. Finally, binding of ﬂuorescein-conjugated
annexin V and PI was measured by ﬂuorescence-activated cell
sorting (Becton Dickinson, Sunnyvale, CA, USA). Apoptosis was
also analysed by measuring active caspase 3 levels by ﬂow
cytometry, using an FITC-labelled antibody (BD Biosciences,
Alphen aan den Rijn, The Netherlands) against the active form
of caspase 3. The cells were ﬁxed and permeabilized with ﬁx
and perm obtained from BD Biosciences.
Preparation of protein extracts and Western blotting
The amounts of p21, ASK1, p38, JNK and actin, and the degree
of phosphorylated p38 and JNK were determined by Western
blotting on whole-cell extracts, cytoplasmic or nuclear extracts.
U937 cell lines were cultured for 3 days in RPMI 1640
supplemented with 10% FBS, with or without ZnCl2 (180mM),
and overnight with VP16 (20mg/ml) or H2O2 (300mM). Cells
were harvested and total cell extracts were prepared by
resuspending the cells in sample buffer (2% SDS, 10% glycerol,
2% b-mercaptoethanol, 60mM Tris-HCl pH 6.8 and bromophe-
nol blue). Cell extracts were directly boiled for 5min, and
proteins were fractionated by running on SDS-PAGE gel. The
proteins were electrophoretically transferred to PVDF mem-
brane (Millipore, Bedford, MA, USA) blocked with TBS buffer
containing 0.1% Tween-20 and 5% nonfat milk, prior to
incubation with antibodies, diluted in 5% bovine serum
albumin. Binding of each antibody was detected by HRP-
labelled secondary antibodies, using enhanced chemilumine-
sence (ECL), according to the manufacturer’s recommendations
(Amersham Life Sciences, Buckinghamshire, UK).
Monocytes and AML blasts were cultured for 24h in RPMI
1640 supplemented with 10% FBS with or without PMA (50nM),
IL-1b (10ng/ml), IL-3 (10ng/ml), GM-CSF (10ng/ml), Ly294002
(5mM), SB203580 (1mM), U0126 (5mM), BIM (1mM), chelerythrin
(6mM) or calphostin-C (100nM), at a density of 1 10
6cells/ml.
Cells were harvested, and cytoplasmic and nuclear extracts
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Leukemiawere prepared according to the ‘mini-extracts’ method.
26 The
extracts were normalized for protein content prior to SDS-PAGE.
Proper fractionation and lack of leakage of nuclear proteins to
the cytosol were determined by Western blotting against the
nuclear protein retinoblastoma (Rb).
To investigate the role of an autocrine growth factor, AML
blasts were cultured for 24h in RPMI 1640 supplemented with
10% FBS, and subsequently stimulated for 6h with conditioned
AML medium (prepared by incubating AML cells at a density of
3 10
6cells/ml for 3 days) or 50nM PMA as a control.
RNA extraction, preparation of cDNA and real-time
PCR
Monocytes (5 10
6) were cultured for 24h in RPMI 1640
supplemented with 10% FCS, and subsequently stimulated for 0,
1, 2 or 3h with 50nM PMA, in the presence and absence of 1mg/
ml actinomycin D. Cells were lysed in 1ml Tri reagent, and
RNA was isolated according to the manufacturer’s recommen-
dations. Brieﬂy, 0.2ml chloroform was added to the Tri reagent
cell mixture, and after 5min at room temperature the RNA was
phase separated into the aqueous phase by centrifuging at
12000g for 15min at 41C. The RNA was precipitated from the
aqueous phase by mixing and centrifuging with 1 volume of
isopropanol for 10min at 12000g at 41C. After washing the
RNA pellet with 1ml 75% ethanol, it was dried and dissolved in
DepC-treated H2O.
The isolated RNA was used to make cDNA. Brieﬂy, annealing
of the random hexamer primers (p(CNA)6) was performed by
incubating 5ml of RNA for 10min at 651C in the presence of the
random hexamer primers, and immediately putting them on ice
afterwards.
The synthesis of the cDNA was then completed by incubating
the samples at 371C for 1h in the presence of 0.5mM dNTPs, M-
MLV-RT polymerase and RNAse inhibitor.
A real-time PCR analysis of p21 expression was performed
using the Quantitect SYBR Green PCR Kit from Qiagen,
following the manufacturer’s instructions on the Light Cycler
system from Roche. The p21 values were normalized against
values obtained by real-time PCR for HPRT. The primers used
were: p21, FOR; tcaccgagacaccactggag, REV cttccaggactg
caggcttc; HPRT, FOR; tggcgtcgtgattagtgatg, and REV gatgtaatc
cagcaggtcag.
Electrophoretic mobility shift assay
Monocytes were cultured for 24h in RPMI 1640 supplemented
with 10% FBS, with or without the addition of SN-50 (100mg/
ml), and subsequently stimulated for 6h with 50nM PMA.
Nuclear extracts were prepared according to the ‘mini-extracts’
procedure as previously described, divided in small aliquots and
stored at –801C.
Double-stranded synthetic oligonucleotide probes containing
the NF-kB (NF-kB: 50-AGCTGCGGGGATTTTCCCTG-30) con-
sensus binding sequence were used in the gel retardation assay.
The consensus sequence for binding of the nuclear factors is
underlined. High-performance liquid chromatography (HPLC)-
puriﬁed single-stranded oligonucleotide (50ng) was labelled
with T4-polynucleotide kinase and [a
32P]dATP (3000Ci/mmol),
separated from nonincorporated radiolabel by sephadex G50
chromatography, ethanol precipitated, dried, and dissolved in
20mlo f1 0m M Tris-HCl (pH 7.5), 50mM NaCl, 10mM MgCl2,
1m M EDTA and 1mM DTT, containing a four-fold excess of the
opposite strand. Annealing of the two strands was performed by
heating the mixture for 2min at 901C, and slow cooling to room
temperature. Nuclear extract (5mg) and 0.1ng double-stranded
labelled oligonucleotide were incubated in 20mM HEPES (pH
7.9), 60mM KCl, 0.06mM EDTA, 0.6mM DTT, 2mM spermidine
and 10% glycerol, supplemented with 2mg poly(dI-dC). The
binding reaction was performed at 261C for 25min. The samples
were loaded on prerun (30min, 150V) 4% (30:1) polyacryla-
mide gels, and run for 1h at 150V in 0.5  TBE at room
temperature. Gels were dried and exposed to Kodak XAR ﬁlms
at  801C with an intensifying screen. Quantiﬁcation of protein
binding was performed by densitometry using a Phosphor
Imager (Molecular Dynamics, Sunnyvale, CA, USA). Competi-
tion experiments were performed by adding a 100-fold molar
excess of unlabelled double-stranded oligonucleotides. Super-
shift experiments were performed by incubating the nuclear
extracts for 30min with polyclonal antibodies against the p50
and p65 subunits of NF-kB.
Immunoprecipitation
AML blasts (10
7) were cultured for 16h in RPMI 1640 medium
supplemented with 10% FBS with or without 50nM PMA. As
positive control, 10
7 cells of the human growth factor-
dependent cell line AS-E2 were cultured for 16h in RPMI
1640 supplemented with 5% FBS and 10ng/ml IL-3. These were
cultured in the presence of 50nM PMA to induce p21
expression. Cells were harvested, washed with ice-cold PBS
containing 1mM sodium orthovanadate, and subsequently lysed
in 500ml lysis buffer (20mM Tris-HCl pH 7.6, 100mM NaCl,
10mM EDTA, 1% NP-40, 10% glycerol, 2mM Na3VO4,2 m M
PMSF, 1mM pepstatin and 1mM DTT) for 15min on ice. Cell
lysates were clariﬁed at 10000g for 20min, and incubated with
10ml p21 agarose conjugate (p21 (C-19) AC Santa Cruz, CA,
USA) rotating O/N at 41C. The immune complex was washed
three times with lysis buffer and heated in sample buffer,
separated by SDS-PAGE, immunoblotted on PVDF membrane
(Millipore, Bedford, MA, USA), and incubated with anti-p21 and
anti-ASK1 antibodies. Immunocomplexes were detected using
ECL (Amersham, UK).
Statistical analysis
The Student’s t-test for paired samples was used to determine the
statistical signiﬁcance of the apoptosis data in the U937 cell
line. The Mann–Whitney U-test was used to determine the
statistical signiﬁcance between the two groups of differentially
expressing p21 AML blasts.
Results
Expression and regulation of p21 in normal monocytes
and myeloid cells
To obtain more information regarding expression, localization
and regulation of p21 in normal haematopoietic cells, and
especially whether p21 is a downstream target of NF-kB, as is
reported earlier,
9 monocytes from healthy donors were stimu-
lated with IL-1b, GM-CSF, IL-3 and the phorbol ester PMA for 4,
6 and 24h. As depicted in Figure 1a, in unstimulated cells, no
p21 protein could be detected, while PMA, IL-3 and GM-CSF all
induced p21 expression, with a predominant cytoplasmic
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Leukemialocalization. Correct fractionation is indicated by the absence of
leakage of the nuclear Rb protein to the cytoplasm. Stimulation
with IL-1b did not result in the appearance of p21 protein,
despite the fact that IL-1 is capable of inducing NF-kB DNA-
binding activity.
27–32 Since the appearance of p21 could reﬂect
increased p21 gene expression or a diminished p21 protein
degradation,
33 a real-time PCR was performed on PMA-
stimulated monocytes. Treatment of monocytic cells from
healthy donors with PMA upto 3h clearly showed an upregula-
tion of p21 gene expression, which could be effectively blocked
by treatment with the polymerase II inhibitor actinomycin D
(Figure 1b). This indicates that PMA can regulate p21 at the level
of gene expression. Next, we determined whether NF-kBi s
activated by PMA and is required for PMA-induced p21
expression. Monocytes were stimulated with PMA and IL-1,
and analysis of DNA binding by NF-kB was performed with an
electrophoretic mobility shift assay (EMSA), as described in
Materials and methods. PMA and IL-1 both induce NF-kB
binding to its consensus binding sequence (Figure 1c). Supershift
experiments with antibodies directed against the NF-kB subunits
p50 and p65 resulted in complexes with a decreased mobility,
indicating the presence of NF-kB in the observed complexes.
Addition of a molar excess of unlabelled probe resulted in a
complete disappearance of IL-1-induced DNA–protein com-
plexes. In order to analyse if the PMA-induced NF-kB activation
is involved in the upregulation of p21 expression, monocytes
were stimulated with PMA in the absence and presence of the
NF-kB inhibitor SN-50. As demonstrated in Figure 1d, SN-50
inhibited the induction of NF-kB DNA-binding activity
Actin
p21 cyto
PMA
SN-50
+ _
_
+
_ +
NF-kB
NF-kB
PMA IL-1 _
_ p50 Ab
p65 Ab
Cold probe IL-1 10'
Actin
_ PMA IL-1 IL-3 GM-CSF _ PMA IL-1 IL-3 GM-CSF
Cytoplasm Nucleus
p21
Rb
0
10
20
30
40
50
F
o
l
d
 
i
n
d
u
c
t
i
o
n
PMA (hrs) 0 123 0 12 3
Actinomycin D
p21 gene
expression
a
b
c
d
Figure 1 Expression and localization of p21 in monocytes. (a)
Monocytes from healthy donors were isolated and cultured as
described in Materials and methods, and stimulated with 50nM
PMA, 10ng/ml IL-1b, 10ng/ml IL-3 and 10ng/ml GM-CSF for 24h.
Nuclear and cytoplasmic fractions were analysed by SDS-PAGE. Rb is
used as a fractionation control. The data presented are representative
for ﬁve individual experiments. (b) Monocytes (5 10
6) were cultured
for 24h in RPMI 1640 supplemented with 10% FCS, and subsequently
stimulated for 0, 1, 2 or 3h with 50nM PMA, in the presence and
absence of 1mg/ml actinomycin D. RNA was isolated and cDNA was
synthesized, as described in Materials and methods. This cDNA was
subjected to real-time PCR, in order to analyse p21 gene expression,
and was normalized against HPRT. The data presented are averaged
from two individual experiments. (c) Monocytes were cultured for 6h
in the presence of 50nM PMA or 10ng/ml IL-1b. EMSAs were used to
detect the DNA-binding activity of NF-kB in nuclear extracts. Controls
with a-p50 and a-p65 antibodies for supershifts and cold probe
competition are shown for IL-1-treated samples, in order to verify that
the observed complex is speciﬁc and contains NF-kB. The data
presented are representative for three individual experiments. (d) After
culturing monocytes for 6h in the presence of 50nM PMA with or
without pretreatment with the speciﬁc NF-kB inhibitor SN-50 (100mg/
ml), nuclear extracts were analysed for the DNA-binding capacity of
NF-kB, in an EMSA. Cytoplasmic extracts were analysed for p21
content by SDS-PAGE. The data presented are representative of two
individual experiments. Cyto¼cytoplasmic.
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Figure 2 Expression and localization of p21 in haematopoietic
cells. (a) Expression of p21 protein in U937, HL-60, GF-D8 and AS-E2
cells. After culturing these cells in the presence or absence of 50nM
PMA for 6h, nuclear and cytoplasmic extracts were analysed for p21
levels by SDS-PAGE. The data presented are representative for two
individual experiments. Cyto¼cytoplasmic, nuc¼nuclear. (b) Expres-
sion of p21 in the primitive cell line KG1a and granulocytes.
Granulocytes were obtained from healthy donors and stimulated with
50nM PMA or 10ng/ml GM-CSF for 6h. KG1a cells were stimulated
with 50nM PMA or 10ng/ml GM-CSF for 6h. Western blot analysis of
whole extracts was performed to demonstrate p21 expression upon
GM-CSF and PMA treatment. Monocytes stimulated with PMA and
GM-CSF were used as positive controls. Actin was used as loading
control. The data presented are representative of four individual
experiments.
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Leukemiain response to PMA stimulation, but did not affect the PMA-
induced p21 expression. These data indicate that in monocytes,
NF-kB is not required for PMA-induced p21 expression.
To further investigate the expression and role of p21 in cells of
monocytic and myeloid origin, granulocytes and the cell lines
KG1a, HL-60, AS-E2, GF-D8 and U937 were stimulated with
GM-CSF or PMA. In none of the unstimulated celllines, p21
could be detected in the nucleus or cytoplasm. Upon stimula-
tion with PMA during 6h, an increase in cytoplasmic and
nuclear p21 was demonstrated in all cell lines studied, which
was most prominent in the monocytic cell line U937 (Figure 2a).
In the primitive KG1a cell line and in granulocytes, PMA- or
GM-CSF-induced p21 expression was low or undetectable
compared to monocytic cells (Figure 2b). These ﬁndings
indicate that in haematopoietic cells, p21 expression is absent
in unstimulated cells, and can be signiﬁcantly upregulated after
induction with PMA, GM-CSF or other cytokines, with the
exception of the KG1a cells and granulocytes. In addition, while
cells of the myeloid lineage showed comparable amounts of
cytoplasmic and nuclear p21, monocytes were observed to have
more p21 protein localized in the cytoplasm after PMA and GM-
CSF treatment (Figures 1a, 2a).
Using chemical inhibitors, the role of various intracellular
signalling routes in regulating p21 expression in monocytes was
investigated. The inhibitors used were U0126, SB203580 and
Ly294002, which block the MEK1, p38 kinase and the PI(3)K
activity, respectively. In monocytes, neither U0126, SB203580,
nor Ly294002 affected PMA- (Figure 3a) and GM-CSF (data not
shown)-induced p21 expression, while the used inhibitors
effectively interfered with the activation of downstream effectors
(Figure 3b). The PKC inhibitors BIM and chelerythrine, however,
strongly inhibited p21 expression. Low concentrations of BIM
display activity on typical and atypical PKC isoforms.
34 Similar
ﬁndings have been described for chelerythrine.
35 The PKC
inhibitor calphostin-C, which has been described to act on
classical and novel PKC isoforms,
35–37 had no effect on p21
expression (Figure 3a). In all cases, localization of the p21
protein was not affected by the use of different inhibitors. The
absence of nuclear p21 after treatment with BIM and
chelerythrin is probably due to the lowered expression levels,
instead of relocalization. These ﬁndings indicate that in
monocytic cells, a PKC-dependent pathway is responsible for
the expression of the p21 protein, although it remains to be
determined which PKC isoform is the main effector of this
process.
p21 expression in AML
In haematopoietic cells, p21 is not expressed in unstimulated
cells, but can be induced by PMA in the monocytic lineage in a
PKC-dependent fashion. In order to see if a similar expression
pattern exists in the malignant counterpart, p21 was studied in
cryopreserved AML cells of either monocytic or myeloid origin.
In contrast to normal unstimulated monocytes, a high constitu-
tive expression of p21 was observed in 75% of the monocytic
leukaemia (M4–5, N¼12), with a predominant cytoplasmic
localization (Figure 4a). In 50% of the myeloid leukaemias
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Figure 3 (a) Expression of p21 in monocytes is inhibited by the PKC inhibitors BIM and chelerythrin. Monocytes from healthy donors were
isolated and cultured as described, and pretreated for 1h with 1mM BIM, 6mM chelerythrin, 100nM calphostin-C, 5mM U0126, 5mM Ly29002 and
1mM SB203580, and stimulated with 50nM PMA for 6h. Nuclear and cytoplasmic fractions were analysed for p21 levels by SDS-PAGE. The data
presented are representative for three individual experiments. Actin is used as a loading control, and proper fractionation is demonstrated by the
lack of Rb immunoreactivity in the cytoplasmic fraction. Cyto¼cytoplasmic, nuc¼nuclear. (b) Validation of the effectiveness of the used
inhibitors. Monocytes were pretreated with 5mM U0126, 5mM Ly29002 and 1mM SB203580 for 1h, and stimulated for 30min with 50nM PMA. P-
Erk, P-PKB and P-p38 are shown. Actin is shown for loading control. The expression of p21 protein in the same samples was analysed after 6h.
Tot¼total.
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Leukemia(M1–2, N¼10), p21 expression could not be detected without
stimulation, or a low expression of p21 was observed, which
was localized in both the nucleus and cytoplasm (Figure 4a;
data not shown). These ﬁndings link aberrant p21 expression
primarily to cells of monocytic origin. To demonstrate whether
PKC is also involved in the spontaneous expression of p21 in
AML cells, blast cells (N¼5) with a high cytoplasmic p21
localization were exposed to the PKC inhibitors BIM and
chelerythrin. Chelerythrin reduced p21 expression in all studied
cases, while BIM inhibited the p21 expression in four of ﬁve
studied cases (Figure 4b). The use of PKC inhibitors only affected
the expression of p21 and not the localization, as demonstrated
in Figure 4b. Rb was used as a fractionation control. These
results underscore a role for PKC-dependent activation of p21
expression in malignant monocytic cells.
Next, we investigated whether the activated signal transduc-
tion pathway leading to constitutive p21 expression might be
due to the autocrine production of a growth factor or a cell-
autonomous effect. Therefore, after 3 days of culture, condi-
tioned medium of monocytic AML blast (M4–5) cultures
(supernatant) was added to cultures of myeloid AML blasts
(M1-2), and p21 expression was analysed (Figure 4c). In one
case, monocytic AML-conditioned medium induced p21
expression in myeloid AML blasts, while in the additional cases
no effects were observed. Since these myeloid AML cells might
have some inherent blockade, the conditioned medium was also
added to monocytes of healthy donors. The AML-conditioned
medium now induced p21 expression in normal monocytes,
although not as high as PMA- or GM-CSF-induced p21
expression (Figure 4c). These results suggest that in monocytic
leukaemia, the autocrine production of growth factors could
lead to constitutive p21 expression. In addition, a cell-
autonomous mechanism of p21 expression cannot be excluded,
and might also contribute to this observation.
Cellular function of p21
It has been demonstrated that cytoplasmic p21 has antiapoptotic
properties in response to stress, due to the interaction between
p21 and ASK1.
10 To investigate whether this applies also to the
effects of cytostatic agents, U937 cells overexpressing p21 and
neomycin-transfected control cells were exposed to VP16 or
H2O2. A signiﬁcant lower percentage of apoptotic cells was
observed in response to VP16 exposure in p21-overexpressing
cells compared to control cells (20.070.9 vs 55.873.8%,
N¼8, Po0.01) (Figure 5a). In addition, p21-negative (N¼6)
and p21-positive (N¼7) AML blasts were subjected to VP16
treatment. As a measure of the apoptotic response, levels of
activated caspase 3 were detected, as well as combined annexin
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Figure 4 Expression of p21 in AML blasts. (a) AML blasts were isolated and cultured as described. Cytoplasmic and nuclear fractions were
analysed for p21 content by SDS-PAGE. Eight representative cases are shown. The data presented are representative of two individual experiments.
(b) AML blasts (M4–5) were isolated and cultured for 24h in the presence of 1mM BIM or 6mM chelerythrin. The p21 protein was detected in
cytoplasmic fractions by means of SDS-PAGE. As controls for subcellular fractionation, Rb protein was used. Two representative cases are shown.
The data presented are representative of two individual experiments. (c) AML blasts (M1–2) were cultured for 24h and stimulated with 50nM PMA
or conditioned AML medium from M4–5 cultures, to study the role of autocrine growth factors leading to p21 expression. Conditioned AML
medium was obtained by culturing 3 10
6 \FS28 AML blasts (M4–5) for 3 days. The same conditioned media were added to normal monocytes, in
order to analyse p21 expression. Stimulation with 50nM PMA or 10ng/ml GM-CSF was used as positive control. Actin is shown as loading control.
The data presented are representative for two individual experiments. Cyto¼cytoplasmic, nuc¼nuclear.
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LeukemiaV/PI stainings, which were both measured using ﬂow cytometry.
The group of AML blasts with high cytoplasmic p21 expression
(N¼7) was signiﬁcantly less sensitive to VP16-induced apop-
tosis as compared to AML blasts with low p21 expression levels
(N¼6), both for the active caspase 3 assay (respectively, 12.3 vs
42.3%, Po0.01) and the combined annexin V/PI experiments
(respectively, 8.5 vs 25.8%, Po0.01) (Figure 5b). Next, it was
investigated whether the reduced apoptosis corresponded to a
reduced phosphorylation, and hence activation of the known
downstream targets of ASK1, p38 and JNK, since these have
been shown to be effectors of ASK1-mediated apoptosis.
38–40 As
depicted in Figure 5c, the protective effect of p21 in the U937
cell line was associated with a reduced phosphorylation of p38
and JNK in p21-overexpressing cells in response to VP-16
triggering. Similar results were obtained with the stress response
activator H2O2 (Figure 5d). To further underscore the connec-
tion between p21 and ASK1, coimmunoprecipitations were
performed with p21 and ASK1 in two AML cases with high
cytoplasmic p21 levels. For this coimmunoprecipitation, an
anti-p21 antibody conjugated to agarose beads was used. As
control for p21 expression and p21–ASK1 complex formation,
untreated AS-E2 cells stimulated with 50nM PMA for 16h were
used. As negative control, unstimulated AS-E2 cells were used,
since unstimulated AS-E2 cells do not express p21 (Figure 2a).
After 16h of PMA (50nM) stimulation, complex formation
between p21 and ASK1 could be observed in the AS-E2 cell line,
indicating that ASK1 co-precipitates with the p21 protein
(Figure 6). In the AML blasts, ASK1 co-precipitated with p21
in all conditions shown. Although in the M5 AML cells, PMA
treatment resulted in more ASK1 immunoreactivity, this is
probably due to increased p21 expression in response to PMA.
The complex formation between p21 and ASK1 itself, however,
does not appear to be PMA dependent, since ASK1 can also be
detected in p21 precipitates from untreated M5 AML cells. In
short, we show that in monocytic leukaemias, cytoplasmic p21
functions as an antiapoptotic protein. This is demonstrated by a
lowered sensitivity towards VP16-induced apoptosis, which is
reﬂected by a decreased phosphorylation of the known down-
stream targets of ASK1, p38 and JNK. The observed complex
formation between p21 and ASK1 further strengthens this
hypothesis.
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Figure 5 The p21 protein affects apoptosis induced by VP16 or
H2O2. (a) Mock-transfected U937 cells or U937 cells stable
transfected with a ZnCl2-inducible p21 construct were cultured for 3
days in the presence of 180mM ZnCl2 to induce p21 expression. Next,
the cells were exposed to 20mg/ml VP16 for 24h, and afterwards
apoptosis was measured using the combined annexin V/PI staining
procedure, as described in Materials and methods. The data presented
are averaged from eight independent experiments, with error bars
denoting standard errors.
nPo0.01. (b) AML blasts were isolated and
cultured as described. After 24h of exposure to 20mg/ml VP16,
apoptosis was measured using the combined annexin V/PI staining by
ﬂow cytometry. Also, levels of activated caspase 3 were measured
using ﬂow cytometry, as described in Materials and methods. For both
experiments,
nPo0.01. (c) The mock- and stable-transfected U937
cells expressing p21 were cultured for 3 days with 180mM ZnCl2, and
apoptosis was induced by culturing in the presence of 20mg/ml VP16.
Activation of JNK and p38 was studied in total cell extracts by Western
analysis. The data presented are representative of ﬁve individual
experiments. (d) Apoptosis was induced in U937 cells stably
overexpressing p21, by culturing these cells for 24h in the presence
of 300mM H2O2. Whole extracts were assayed for phosphorylated JNK
by Western analysis. The data presented are representative of ﬁve
individual experiments.
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Figure 6 The p21 protein forms a complex with ASK1 in
monocytic AML blasts and AS-E2 cells. AML blasts (10
7; M4–5) were
cultured in the absence or presence of 50nM PMA for 16h as
indicated. Cell lysates were subjected to p21 immunoprecipitation
(IP), using an a-p21 antibody, conjugated to agarose beads.
Immunoblotting was performed using a-p21 and a-ASK1 antibodies.
Expression of ASK1 in all samples was conﬁrmed by immunoblotting
of total cell extracts; see the ‘input’ panel. As negative and positive
controls, 10
7 AS-E2 cells were grown in the absence or presence of
50nM PMA, respectively, and IP was performed. The data presented
are representative of ﬁve individual experiments.
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LeukemiaDiscussion
The role of nuclear p21 as a cell cycle regulator by interaction
with several cyclin-dependent kinases is well established.
12–16
Recent studies have indicated that p21 might have an additional
function when the protein is localized in the cytoplasm.
Cytoplasmic p21 is linked to the antiapoptotic process, by
interacting with ASK1 or procaspase 3.
10,19,41,42 The present
study indicates that in differentiating haematopoietic cells of
monocytic and myeloid lineage, p21 can be selectively
upregulated by a number of cytokines, which in monocytic
cells is a PKC-dependent but NF-kB-independent process. A
recent study in monocytes indicated a link between NF-kB
activation and p21 upregulation, suggesting that p21 might
accomplish the antiapoptotic effects of NF-kB.
9 However,
in the present study, it is shown that NF-kB activity is not
required for p21 expression. In monocytic leukaemia, constitu-
tively expressed p21 is frequently observed in contrast
to myeloid leukaemia, which is a PKC-dependent process.
This is likely linked to the autocrine production of growth
factors. However, it is not strictly excluded that a yet
unknown upstream kinase or receptor mutation results in the
constitutive activation of this signal transduction pathway,
leading to constitutive p21 expression. The PKC-dependent
expression of p21 is not linked to the MEK1 or PI(3)K signalling
pathways. This is in contrast with other reports, where it was
shown that p21 protein stability is enhanced by phosphorylation
through PKB,
20 and where PMA-induced p21 expression is
linked to nuclear distributed ERK.
43 In addition, phosphorylation
of p21 on Thr
145 is suggested to be a prerequisite for its
cytoplasmic localization.
44 Whether the localization of p21 is
dependent on the phosphorylation status of the protein in
conjunction with the cellular setting is the subject of further
research.
Finally, it is shown that p21 overexpression inhibits VP16-
mediated apoptosis, as reﬂected by the inhibitory effects on
the phosphorylation of p38 and JNK, known downstream
targets of ASK1. In addition, p21 and ASK1 form a complex in
cell lines and AML blasts, underscoring a strong connection
between the antiapoptotic function of p21- and ASK1-mediated
apoptosis. The results obtained in monocytes are in disagree-
ment with the ﬁndings by Asada et al,
10 who demonstrated that
unstimulated monocytes express p21. The cause of this
difference is unclear, but might be related to the isolation
procedure used.
The data presented here and other ﬁndings indicate that,
in leukaemic cells, antiapoptotic proteins are regulated by
different signalling routes, including the RAS/PI(3)K/NF-kB
pathway,
4,6–8,45 the STAT3 and STAT5 pathways
5,46 and in
monocytic blasts also at the level of p21 expression.
9,10,17 These
ﬁndings illustrate that, until a single oncogenic defect that is
responsible for the total spectrum of activation signals is deﬁned,
combination of inhibitors has to be used for chemotherapeutic
interference with the distinct and overlapping activated signal-
ling routes.
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